Chris Kim
Chief Executive Officer at Liminatus Pharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Liminatus Pharma Inc., 1 year.
Liminatus Pharma Inc.
Director · Chief Executive Officer
Chief executive roles
Liminatus Pharma Inc.
· Chief Executive Officer
Since April 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Liminatus Pharma Inc. | Other | +3,448,926 | — | — |
| Jun 24, 2026 | Liminatus Pharma Inc. | Other | −4,373,603 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.